Stay updated on Oral Gallium Maltolate for Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.

Latest updates to the Oral Gallium Maltolate for Glioblastoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect a new phase 2 study of Gallium maltolate for glioblastoma, with changes in dosage recommendations and the removal of extensive details about the previous phase 1 study.SummaryDifference28%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 12, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.2%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check52 days agoChange DetectedThe webpage has updated its date references, removing older dates and adding new ones for March 2025.SummaryDifference0.8%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
Stay in the know with updates to Oral Gallium Maltolate for Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.